A detailed history of Nisa Investment Advisors, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 200 shares of ROIV stock, worth $2,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 75 166.67%
Holding current value
$2,400
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$10.17 - $12.5 $1,271 - $1,562
125 Added 166.67%
200 $2,000
Q2 2024

Jul 19, 2024

BUY
$10.36 - $11.74 $777 - $880
75 New
75 $0

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.45B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.